Paradigm Medical Industries, Inc.
http://www.paradigm-medical.com/press_06252013.html Paradigm Medical Industries (PDMI)
Originally the creation of a merger between French Bar Industries and Paradigm Medical Inc. in early 1993, the company quickly became skilled in the development, manufacturing, sales, and marketing of medical devices utilizing innovative and dependable diagnostic technologies for the early detection of glaucoma and other eye disorders.
Paradigm Medical Industries, Inc. has an exceptional history of acquiring superior medical devices and companies. In 1997 Paradigm acquired OBF Labs and the Ocular Blood Flow Analyzer (BFA). Today the BFA is the only medical device available that measures both IOP and Ocular Blood Flow, two key factors in the assessment and early treatment of glaucoma, circulatory abnormalities, and other eye maladies. In 1998 the company acquired proprietary UBM technology from Humphrey Systems. After extensive research and development Paradigm enhanced this technology to be more precise, user friendly, and detailed with its introduction of the P60 UBM, the first Windows based UBM, in early 2005. In 2000 Paradigm acquired Dicon, a manufacturer of advanced diagnostic instrumentation, and expanded its product line to include perimetry, topography, and pachymetry. Only Paradigm’s sophisticated perimeters perform testing strategies with voice recognition software, now available in 26 languages. Paradigm remains dedicated to developing or acquiring new technologies and devices that preserve the vision of tomorrow, today.
Paradigm’s expertise lies with medical devices using UBM, A-scan, B-scan, pachymetry, perimetry, ocular electrophysiology, topography, tomography, and tonometry technologies. With over 17 years of experience Paradigm specializes in providing reliable, easy-to use equipment that provide the experienced practitioner unequalled value and performance, while remaining affordable for physicians starting new practices or opening up additional satellite offices.
Paradigm Medical Industries, Inc. is a publicly owned company traded on the OTC/PK under the symbol PDMI. Two Consultants for PDMI
Steven Bayern & Thomas F. Motter Steven Bayern BIO Listed as Consultant in PR
Mr. Bayern has over 30 years of experience in investment banking, venture capital, and trading
and brokerage management, including having founded and served as a principal in three separate brokerage firms on Wall Street. He was founder and principal of Racz & Company, a NYSE member firm, founder and Chairman of S.J. Bayern & Company, an NASD member firm, and founder and Chairman of Win Capital Corporation, also an NASD member firm. Mr. Bayern was also involved in successfully raising capital for Paradigm Medical in 2001 and 2003, and in arranging for the merger between the Company and Vismed, Inc., dba Dicon in 2000.
Holding an MBA from the Baruch School of Business CCNY earned in 1974, in Finance and Investments, Mr. Bayern has built his career in the financial industry based upon his ability to locate, structure and fund small cap and mid-market deals. To that end, he has consummated myriad transactions throughout his career while compiling a long and distinguished track record of success.
In his capacity as a principal in broker/dealer ventures, Mr. Bayern has assisted a great many small and mid-size companies achieve public listing and trading status and is intimately familiar with the public equity markets on both the buy and sell sides.
Having worked with numerous companies throughout the course of his career and having raised many hundreds of millions of dollars in equity capital for them, Mr. Bayern brings an invaluable skill-set and wealth of experience to any company in search of capital. His ability to locate, structure and shepherd transactions throughout the process is critical and his connections at virtually every level of Wall Street is of vital importance to any company seeking seed, bridge, mezzanine or ongoing capital up to and beyond the domestic sources serve to compliment the success of any client’s funding endeavors.
Racz & Company Mentioned here in NY Times Article 1981
http://www.nytimes.com/1981/09/29/business/big-rally-calms-traders-early-fears.html Thomas F. Motter is no scrub promoter IMO... Check out his BIO
Quote: SmithKline Beckman was merged with what ultimately became GSK one of the largest pharma companies behind Pfizer
Mr. Motter has worked in the eye care industry for over 30 years, including management
positions at SmithKline Beckman's eye division over a 15 year period. Mr. Motter founded Paradigm
Medical and served as Chairman of the Board and Chief Executive Officer of the Company from 1993
to 2002. As founder of Paradigm Medical, Mr. Motter pioneered the use of Nd-yag laser for cataract
removal and was at the forefront in the introduction of new surgical procedures utilizing ultrasound and
laser technologies in all facets of soft tissue management.
The Beecham Group plc was a British pharmaceutical company. It was once a constituent of the FTSE 100 Index. Beecham, after having merged with SmithKline Beckman, merged with Glaxo Wellcome to become GlaxoSmithKline (GSK). GSK still uses the Beechams brand name in the UK for its over-the-counter cold and flu relief products.